Similar companies
| Company | Stocktwits Mentions | |
|---|---|---|
 |
Johnson & JohnsonJNJ |
283 0.4% |
 |
Eli Lilly and CompanyLLY |
168 15.1% |
 |
PfizerPFE |
186 5.6% |
 |
AstrazenecaAZN |
32 0% |
 |
AbbVieABBV |
95 5.6% |
APUS Stocktwits Mention Trend
Apimeds Pharmaceuticals (APUS) is averaging 67 mentions a day on Stocktwits, up 1017% from three months ago, a sign of elevated retail interest. Mention volume is spiky by nature, tending to surge around earnings, news, and price breakouts, so day-to-day swings are normal.
At 67 mentions a day, Apimeds Pharmaceuticals draws less daily Stocktwits chatter than industry peers like Johnson & Johnson (283 a day) and Eli Lilly and Company (168 a day).
What Do Stocktwits Mentions Say About APUS Sentiment?
Stocktwits sentiment for APUS: 85 / 100 — Bullish. This is the bullish-versus-bearish balance of Stocktwits posts specifically; for the blended average across Reddit, StockTwits, and TipRanks, see APUS overall sentiment.
Mention volume is a real-time read on retail interest: a sustained pickup in Stocktwits chatter often reflects shifting attention toward a stock, though it does not say which way the price will move — that is what the Stocktwits sentiment score above captures. AltIndex feeds Apimeds Pharmaceuticals’s Stocktwits activity into the APUS AI Score as one of 25+ alternative data signals, weighed against Reddit and X chatter, fundamentals, and more.
For social activity on other platforms, see APUS Reddit mentions and APUS X mentions. For the size of the community following the stock, see APUS Stocktwits subscribers. To see which tickers are most talked about, view the most mentioned Stocktwits stocks.
Month over Month
| Sep 2026 | 174 | |
| Aug 2026 | 97 | |
| Jul 2026 | 49 | |
| Jun 2026 | 2 | |
| May 2026 | 35 | |
| Apr 2026 | 3 |
Apimeds Pharmaceuticals Stocktwits Mentions: Frequently Asked Questions
Apimeds Pharmaceuticals (APUS) is averaging 67 mentions a day on Stocktwits. Mention volume is event-driven, so it tends to spike around earnings, news, and sharp price moves rather than holding steady.
See the APUS Stocktwits subscriber count for the size of the community tracking the stock — a more stable figure than daily mention volume.
Stocktwits mention volume is a proxy for real-time retail interest. A spike often flags an earnings reaction, news event, or price breakout, but on its own it does not predict direction. That is why AltIndex combines APUS’s Stocktwits chatter with sentiment, Reddit and X mentions, and 20+ other signals in its AI Score rather than reading any one signal in isolation.
Apimeds Pharmaceuticals underperforms its industry peers when it comes to Stocktwits Mentions, ranking in the 6th percentile.
AltIndex updates the data on Apimeds Pharmaceuticals' mentions on StockTwits daily. This frequent update schedule ensures that investors have access to the most current insights into market sentiment and discussion dynamics related to Apimeds Pharmaceuticals' on the platform.
Sign up and get more insights on Apimeds Pharmaceuticals.
See Apimeds Pharmaceuticals’s complete stocktwits mentions history
Sign up to unlock 1-year and all-time charts for APUS, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREE
